Literature DB >> 6606644

Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

L S Si, T L Whiteside, R R Schade, D H Van Thiel.   

Abstract

Monoclonal antibodies to antigens on the surfaces of mononuclear cells (MNC) were used to characterize lymphocyte subpopulations infiltrating portal areas and parenchyma of livers in 31 patients with chronic active hepatitis (CAH). The distribution and numbers of infiltrating lymphocytes were determined in serial sections immunostained by the avidin-biotin-peroxidase complex method. T lymphocytes were the major component of inflammatory cells in the portal tracts. In the peripheral blood and portal areas, T helper-inducer (T4+) cells were the more numerous subpopulation. However, the hepatic lobules and areas of "piecemeal" necrosis always contained more T suppressor-cytotoxic (T8+) cells. The latter were demonstrated in contact with HBsAg-containing hepatocytes in tissues of patients with HBsAg-positive CAH. The mean numbers of T lymphocytes infiltrating the portal and periportal areas of livers from patients with HBsAg-negative and HBsAg-positive CAH were not different. Large numbers of B cells forming distinct follicles were seen in tissues from patients with HBsAg-positive CAH. The presence of increased numbers of portal T and B lymphocytes correlated with progressive liver damage as observed in two patients studied at yearly intervals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606644     DOI: 10.1007/bf00915803

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

1.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

Review 2.  Immunologic aspects of liver diseases.

Authors:  F Paronetto
Journal:  Prog Liver Dis       Date:  1970

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Morphologic association of lymphocytes with hepatocytes in chronic liver disease.

Authors:  H Kawanishi
Journal:  Arch Pathol Lab Med       Date:  1977-06       Impact factor: 5.534

Review 5.  Genetic determinants of autoimmune chronic active hepatitis.

Authors:  I R Mackay; S Whittingham; J D Mathews; B D Tait
Journal:  Springer Semin Immunopathol       Date:  1980-12

6.  Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

Authors:  G S Wood; R Warnke
Journal:  J Histochem Cytochem       Date:  1981-10       Impact factor: 2.479

7.  Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

Authors:  F V Chisari; J A Routenberg; T S Edgington
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

9.  In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

Authors:  J M Vierling; D L Nelson; W Strober; D M Bundy; E A Jones
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

10.  Alterations of T-cell subsets in primary biliary cirrhosis.

Authors:  A K Bhan; J L Dienstag; J R Wands; S F Schlossman; E L Reinherz
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

View more
  9 in total

1.  The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.

Authors:  Y K Yoo; J B Gavaler; K Chen; T L Whiteside; D H van Thiel
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Clinical and immunopathological studies of pars planitis in a family.

Authors:  R P Wetzig; C C Chan; R B Nussenblatt; A G Palestine; D O Mazur; K K Mittal
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

3.  Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha.

Authors:  D H Van Thiel; X Zhang; N Baddour; H I Wright; L Friedlander; J S Gavaler
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 4.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Phenotypic characterization of mononuclear infiltrate present in liver of biliary atresia.

Authors:  K Chen; J S Gavaler; D H Van Thiel; T Whiteside
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

6.  Alpha-interferon. Its effect upon lymphocyte subpopulations and HLA-DR expression within the liver.

Authors:  Y K Yoo; J S Gavaler; K N Chen; V Dindzans; D E Brouillette; T L Whiteside; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

7.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 8.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

9.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.